The analysis by BMI revealed that ALL survivors with normal weight had higher concentrations of Apo-A1, Apo-A2, and apolipoprotein J (Apo-J), and lower concentration of apolipoprotein D (Apo-D), compared to the control patients with normal body weight (Apo-A1: 263.93 ± 139.68 vs. 135.25 ± 67.16 mg/dL; Apo-A2: 25.34 ± 6.07 vs. 18.00 ± 8.78 mg/dL; Apo-J: 11.45 ± 3.70 vs. 9.59 ± 2.88 mg/dL; Apo-D: 3.63 ± 0.72 vs. 28.74 ± 28.90 mg/dL; p < 0.05; Table 2). This evidence concerns the gene CLU and acute lymphoblastic leukemia.